In adrenal cancer NCI-H295 cells, EGCG was shown to drive activity of caspase-8, the downstream target of Fas, and to promote Fas-mediated induction of this signaling cascade to drive apoptosis [95]. The gene discussed is FAS; the disease is adrenal gland cancer.